The balancing act after pediatric venous thromboembolism.
作者信息
Whitworth Hilary, Raffini Leslie
机构信息
Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA.
出版信息
Blood Adv. 2025 Aug 12;9(15):3905-3906. doi: 10.1182/bloodadvances.2025016871.
Abstract
摘要
相似文献
1
The balancing act after pediatric venous thromboembolism.小儿静脉血栓栓塞后的平衡行为
Blood Adv. 2025 Aug 12;9(15):3905-3906. doi: 10.1182/bloodadvances.2025016871.
2
Venous thromboembolism prophylaxis in the pediatric trauma population.儿科创伤患者的静脉血栓栓塞预防。
J Pediatr Surg. 2013 Jun;48(6):1413-21. doi: 10.1016/j.jpedsurg.2013.02.059.
3
A systematic review and meta-analysis for the association between duration of anticoagulation therapy and the risk of venous thromboembolism in patients with lower limb superficial venous thrombosis.一项系统回顾和荟萃分析，评估下肢浅静脉血栓形成患者抗凝治疗持续时间与静脉血栓栓塞风险的相关性。
J Vasc Surg Venous Lymphat Disord. 2024 Mar;12(2):101726. doi: 10.1016/j.jvsv.2023.101726. Epub 2023 Nov 24.
4
Waiting to initiate venous thromboembolism prophylaxis increases the incidence of venous thromboembolism in pediatric patients with traumatic bleeding.等待开始静脉血栓栓塞预防措施会增加创伤性出血儿科患者静脉血栓栓塞的发生率。
J Trauma Acute Care Surg. 2025 Sep 1;99(3):382-386. doi: 10.1097/TA.0000000000004670. Epub 2025 Jun 13.
5
[Venous Thromboembolism in Pediatric Age: A 15 Year Retrospective Review].[儿童期静脉血栓栓塞症：一项15年回顾性研究]
Acta Med Port. 2018 Sep 28;31(9):489-495. doi: 10.20344/amp.9639.
6
How I approach pharmacological thromboprophylaxis in children.我对儿童进行药物性血栓预防的方法。
Blood. 2025 May 22;145(21):2439-2446. doi: 10.1182/blood.2024026327.
7
Stop the Clot: A Quality Improvement Initiative to Reduce the Rate of Venous Thromboembolism in the PICU.阻止血栓形成：一项旨在降低儿科重症监护病房静脉血栓栓塞发生率的质量改进举措。
Pediatr Crit Care Med. 2025 Aug 7. doi: 10.1097/PCC.0000000000003809.
8
Venous thromboembolism in the setting of pediatric central diabetes insipidus: a systematic review of the literature and report of 2 cases.儿童中枢性尿崩症并发静脉血栓栓塞症：文献系统回顾及 2 例报告。
J Neurosurg Pediatr. 2022 Feb 25;29(5):580-589. doi: 10.3171/2022.1.PEDS21469. Print 2022 May 1.
9
Impact of Embedding a Venous Thromboembolism Risk Assessment Model in the Electronic Health Record Versus Usual Care: A Cluster-Randomized Trial.将静脉血栓栓塞风险评估模型嵌入电子健康记录与常规护理的比较：一项整群随机试验
Circ Cardiovasc Qual Outcomes. 2025 Aug;18(8):e010359. doi: 10.1161/CIRCOUTCOMES.123.010359. Epub 2024 Feb 6.
10
Risk Factors for Venous Thromboembolism in Pediatric Trauma Patients and Validation of a Novel Scoring System: The Risk of Clots in Kids With Trauma Score.小儿创伤患者静脉血栓栓塞的危险因素及一种新型评分系统的验证：创伤患儿血栓风险评分
Pediatr Crit Care Med. 2016 May;17(5):391-9. doi: 10.1097/PCC.0000000000000699.
本文引用的文献
1
Recurrent thrombosis and major bleeding in children treated for VTE.接受静脉血栓栓塞症治疗的儿童复发性血栓形成和严重出血。
Blood Adv. 2025 Aug 12;9(15):3824-3831. doi: 10.1182/bloodadvances.2025016135.
2
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.儿童急性静脉血栓栓塞症的延长阶段抗凝治疗：来自EINSTEIN-Jr 3期试验的队列研究
Lancet Haematol. 2025 May;12(5):e357-e364. doi: 10.1016/S2352-3026(25)00067-5. Epub 2025 Apr 10.
3
Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.更新的儿童静脉血栓栓塞症临床试验疗效和安全性结局指导：ISTH SSC 儿科和新生儿血栓形成与止血小组委员会的交流。
J Thromb Haemost. 2023 Jun;21(6):1666-1673. doi: 10.1016/j.jtha.2023.03.004. Epub 2023 Mar 14.
4
High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.儿童和青少年特发性静脉血栓栓塞患者的复发性静脉血栓栓塞率较高。
J Thromb Haemost. 2023 Jan;21(1):47-56. doi: 10.1016/j.jtha.2022.11.031. Epub 2022 Dec 22.
5
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.抗凝治疗 6 周与 3 个月对 21 岁以下有诱因的静脉血栓栓塞症患者的复发和出血事件的影响：Kids-DOTT 随机临床试验。
JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
6
Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis.预防中心静脉导管相关性静脉血栓形成患儿的复发性血栓事件。
Blood. 2022 Jan 20;139(3):452-460. doi: 10.1182/blood.2021013453.
7
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.达比加群酯治疗儿童急性静脉血栓栓塞症（DIVERSITY）：一项随机、对照、开放标签、2b/3 期、非劣效性试验。
Lancet Haematol. 2021 Jan;8(1):e22-e33. doi: 10.1016/S2352-3026(20)30368-9. Epub 2020 Dec 5.
8
Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children.外周置入中心静脉导管会导致儿童发生静脉血栓栓塞的风险增加。
Blood. 2020 Jan 16;135(3):220-226. doi: 10.1182/blood.2019002260.
9
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.达比加群酯在儿童中的静脉血栓栓塞症二级预防中的安全性。
Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.
10
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.利伐沙班与标准抗凝剂治疗儿童急性静脉血栓栓塞症的比较：一项随机、对照、3期试验
Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5.
Zotero 插件